Inter-relationship between lipoprotein and glucose metabolism-analysis using stable isotope study
脂蛋白和葡萄糖代谢之间的相互关系——使用稳定同位素研究进行分析
基本信息
- 批准号:17590949
- 负责人:
- 金额:$ 1.92万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2005
- 资助国家:日本
- 起止时间:2005 至 2006
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Metabolic syndrome is characterized by impaired lipid and glucose metabolism based upon central obesity and insulin resistance. In this sense, interrelationship between lipid and glucose metabolism has been expected. In order to elucidate this possible relationship, we employed triple tracer study in which stable isotopically labeled leucine, glycerol, and glucose are injected to investigate apoliporotein, VLDL glycerol, and glucose metabolism, respectively. Pitavastatin reduced VLDL apoB levels by 43%, which was due combined to 39% increase in catabolism and 23% reduction of production. As to IDL, IDL apoB levels were decreased by 44% which was primarily due to 44% increase in catabolism. LDL apoB was decreased by 33% and this was entirely due to the increased LDL apoB catabolism. VLDL TG reduction was due to increased catabolism as well as reduction of production. Pitavastatin had no significant influence on either insulin sensitivity or glucose sensitivity. Correlation analysis revealed that insulin sensitivity correlated positively with VLDL apoB metabolism. These observation therefore suggest that apoliporpoteins and glucose metabolism associated each other and potent statin such as pitavasitatin could be effective to favorably modify lipid abnormalities typically observed in patients with metabolic syndrome.
代谢综合征的特征是基于中心性肥胖和胰岛素抵抗的脂质和葡萄糖代谢受损。从这个意义上说,脂质和葡萄糖代谢之间的相互关系是可以预期的。为了阐明这种可能的关系,我们采用了三重示踪剂研究,其中注射稳定同位素标记的亮氨酸、甘油和葡萄糖,分别研究载脂蛋白、VLDL 甘油和葡萄糖代谢。匹伐他汀使 VLDL apoB 水平降低 43%,这是由于分解代谢增加 39%,产量减少 23%。至于 IDL,IDL apoB 水平下降了 44%,这主要是由于分解代谢增加了 44%。 LDL apoB 降低了 33%,这完全是由于 LDL apoB 分解代谢增加。 VLDL TG 减少是由于分解代谢增加以及产量减少。匹伐他汀对胰岛素敏感性或葡萄糖敏感性没有显着影响。相关分析显示胰岛素敏感性与VLDL apoB代谢呈正相关。因此,这些观察结果表明,载脂蛋白和葡萄糖代谢相互关联,并且有效的他汀类药物(例如匹伐他汀)可以有效地改善通常在代谢综合征患者中观察到的脂质异常。
项目成果
期刊论文数量(15)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
In vivo turnover study demonstrates diminished clearance of lipoprotein(a) in hemodialysis patients
- DOI:10.1038/sj.ki.5002131
- 发表时间:2007-05-01
- 期刊:
- 影响因子:19.6
- 作者:Frischmann, M. E.;Kronenberg, F.;Dieplinger, H.
- 通讯作者:Dieplinger, H.
Metabolism of ApoB lipoproteins of intestinal and hepatic origin during constant feeding of small amounts of fat.
持续喂食少量脂肪期间,肠道和肝脏来源的 ApoB 脂蛋白的代谢。
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Shinohara T;Ueda A;Abe-Dohmae S.;Tsujita M.;Hayashi M.;Tsujita M. et al.;Hayashi M. et al.;Cuchel M;Frischmann ME;Mochizuki S;Cuchel M;Cuchel M;Frischmann ME;Mochizuki S;Nishiwaki M;Zheng C;Abe Y;Nishiwaki M;Zheng C
- 通讯作者:Zheng C
Reduction in Cholesterol in Homozygous Familial Hypercholesterolemia with an Inhibitor of the Microsomal Triglyceride Transfer Protein.
使用微粒体甘油三酯转移蛋白抑制剂降低纯合子家族性高胆固醇血症中的胆固醇。
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Oike;Y.;Akao;M.;Kubota;Y.;Suda;T.;Cuchel M
- 通讯作者:Cuchel M
Human lecithin:cholesterol acyltransferase deficiency: in vivo kinetics of low-density lipoprotein and lipoprotein-X.
人卵磷脂:胆固醇酰基转移酶缺乏症:低密度脂蛋白和脂蛋白-X 的体内动力学。
- DOI:10.1161/01.atv.0000217910.90210.99
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Nishiwaki,Masato;Ikewaki,Katsunori;Bader,Giovanni;Nazih,Hassan;Hannuksela,Minna;Remaley,AlanT;Shamburek,RobertD;BrewerJr,HBryan
- 通讯作者:BrewerJr,HBryan
Pravastatin prevents myocardium from ischemia-induced fibrosis by protecting vascular endothelial cells exposed to oxidative stress
- DOI:10.1007/s10557-006-9525-7
- 发表时间:2006-08-01
- 期刊:
- 影响因子:3.4
- 作者:Abe, Yuichi;Izumi, Takehiko;Mochizuki, Seibu
- 通讯作者:Mochizuki, Seibu
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
IKEWAKI Katsunori其他文献
IKEWAKI Katsunori的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('IKEWAKI Katsunori', 18)}}的其他基金
Effects of statin on apolipoprotein metabolism in patients with hemodialysis
他汀类药物对血液透析患者载脂蛋白代谢的影响
- 批准号:
22591002 - 财政年份:2010
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Effects of apoA-II, C-I, C-II on in vivo metabolism of apoB-containing lipoproteins-stable, isotope study
apoA-II、C-I、C-II 对含 apoB 脂蛋白体内代谢的影响-稳定同位素研究
- 批准号:
14571110 - 财政年份:2002
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
In vivo evidence of a delayed catabolism of remnant and decreased production of apoA-I in patients with chronic renal failure. -A stable isotope study.
慢性肾功能衰竭患者残余物分解代谢延迟和 apoA-I 产生减少的体内证据。
- 批准号:
11671054 - 财政年份:1999
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
磷脂转运蛋白通过磷酸鞘氨醇1影响高密度脂蛋白抗动脉粥样硬化功能的分子机制
- 批准号:81070247
- 批准年份:2010
- 资助金额:33.0 万元
- 项目类别:面上项目
脂蛋白脂肪酶对老年认知障碍的影响机制与生物学意义
- 批准号:30973145
- 批准年份:2009
- 资助金额:39.0 万元
- 项目类别:面上项目
细菌脂蛋白(BLP)诱导LPS交叉耐受的分子机理研究
- 批准号:30471791
- 批准年份:2004
- 资助金额:20.0 万元
- 项目类别:面上项目
相似海外基金
The Role of Lipids in Alzheimer's Disease and Related Dementias among Black Americans: Examining Lifecouse Mechanisms
脂质在美国黑人阿尔茨海默病和相关痴呆中的作用:检查生命机制
- 批准号:
10643344 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Structurally engineered furan fatty acids for the treatment of dyslipidemia and cardiovascular disease
结构工程呋喃脂肪酸用于治疗血脂异常和心血管疾病
- 批准号:
10603408 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Aspirin, Lp(a) and Primary Prevention of Cardiovascular Events
阿司匹林、Lp(a) 和心血管事件的一级预防
- 批准号:
10720757 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Novel Mechanisms Underlying the Development of Atherosclerosis
动脉粥样硬化发展的新机制
- 批准号:
10589484 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Computational Development of Novel Dyslipidemia Therapeutic Candidates to Disrupt ApoC-III Conformation
破坏 ApoC-III 构象的新型血脂异常治疗候选物的计算开发
- 批准号:
10760187 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Regulation of Endothelial Lipase and HDL Metabolism by ANGPTL3
ANGPTL3 对内皮脂肪酶和 HDL 代谢的调节
- 批准号:
10582972 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Identification of plasma lipoprotein proteins and lipids as biomarkers of innate-immunity and vascular contributions to Alzheimer's disease and Alzheimer's disease-related dementias in older adults
鉴定血浆脂蛋白和脂质作为老年人阿尔茨海默病和阿尔茨海默病相关痴呆的先天免疫和血管贡献的生物标志物
- 批准号:
10660037 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Aspirin for Primary Prevention of Cardiovascular Disease in Patients with Elevated Lipoprotein(a)
阿司匹林用于脂蛋白升高患者心血管疾病的一级预防(a)
- 批准号:
10739016 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别: